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Abstract
Aims/hypothesis The aim of this study was to investigate the
association between routine vaccinations and the risk of child-
hood type 1 diabetes mellitus by systematically reviewing the
published literature and performing meta-analyses where
possible.
Methods A comprehensive literature search was performed of
MEDLINE and EMBASE to identify all studies that com-
pared vaccination rates in children who subsequently devel-
oped type 1 diabetes mellitus and in control children. ORs and
95% CIs were obtained from published reports or derived
from individual patient data and then combined using a ran-
dom effects meta-analysis.
Results In total, 23 studies investigating 16 vaccinations met
the inclusion criteria. Eleven of these contributed to meta-
analyses which included data from between 359 and 11,828
childhood diabetes cases. Overall, there was no evidence to
suggest an association between any of the childhood vaccina-
tions investigated and type 1 diabetes mellitus. The pooled
ORs ranged from 0.58 (95% CI 0.24, 1.40) for the measles,
mumps and rubella (MMR) vaccination in five studies up to
1.04 (95% CI 0.94, 1.14) for the haemophilus influenza
B (HiB) vaccination in 11 studies. Significant heterogeneity
was present in most of the pooled analyses, but was markedly
reduced when analyses were restricted to study reports with
high methodology quality scores. Neither this restriction by
quality nor the original authors’ adjustments for potential con-
founding made a substantial difference to the pooled ORs.
Conclusions/interpretation This study provides no evidence
of an association between routine vaccinations and childhood
type 1 diabetes.




DTP Diphtheria, tetanus and pertussis
HiB Haemophilus influenza B
MMR Measles, mumps and rubella
NOS Newcastle–Ottawa scale
Introduction
Despite much research attempting to identify perinatal risk
factors of childhood type 1 diabetes mellitus, the environmen-
tal factors thought to trigger autoimmune destruction of the
insulin-producing cells in the pancreas remain largely
unknown [1]. An increasing incidence of type 1 diabetes in
childhood has been reported from most regions worldwide
[2, 3] strongly suggesting that there are modifiable risk factors
involved in its aetiology. Although not conclusive, evidence
suggests that the origin of this increase dates from the middle
of the last century [4]. It has been noted that this increase
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parallels the introduction of mass childhood vaccination
programmes in developed countries [5]. This has led to spec-
ulation that the immune-modifying effects of vaccinations in
early childhood, particularly at a formative age for the devel-
oping immune system, might play a part in the rising inci-
dence of type 1 diabetes. Infectious diseases could play a part
in the pathogenesis of type 1 diabetes by disturbing the
developing immune system and so interfering with its future
self-/nonself-discrimination capacity [6]. This rationale may
be related to the hypothesis that limited exposure to infections
and more extensive use of vaccinations early in life can lead to
an increased risk of childhood diabetes [7, 8]. A lack of expo-
sure to infections may limit the education of T cell repertoire
in the developing immune system and, as a result, there may
be an inappropriate response to a subsequent infection.
Although a number of epidemiological studies have inves-
tigated routine vaccinations and type 1 diabetes, the risk esti-
mates from individual studies often lack power because of
small sample sizes. Moreover, it is difficult to make overall
conclusions about vaccinations because results are spread
over a large number of studies. Thus, a meta-analysis of such
studies could provide a better assessment of the effect of rou-
tine vaccinations on the risk of childhood type 1 diabetes and
provide a succinct summary of the literature.
Consequently, the aim of our study was to investigate the
association between routine vaccinations and risk of child-
hood type 1 diabetes mellitus by systematically reviewing
the published literature and performing meta-analysis where
possible.
Methods
Literature searchA search strategy was developed (electronic
supplementary material [ESM] Table 1) and a literature search
was conducted using OvidMEDLINE (US National Library of
Medicine, Bethesda, MD, USA). A similar search strategy was
adopted using EMBASE (Reed Elsevier, Amsterdam, the
Netherlands). The search included articles from the earliest
available date of each database (1947 for both) through to the
first week of July 2013. No language restrictions were made
and conference proceedings were included.
The screening process was conducted independently by
two investigators (S. R. Halliday and E. Morgan). Titles from
the literature search were screened and those that were obvi-
ously irrelevant were removed. Following this, titles and ab-
stracts were reviewed to identify relevant articles. In cases
where relevancy could not be determined by reviewing the
abstract, full text papers were requested and assessed.
Reference lists of the selected articles were manually screened
to identify articles that were not found in the initial search and
further searches were performed for articles that had cited any
of the articles already identified.
Articles were reviewed based on the following inclusion
criteria: studies assessed vaccinations in children and young
adults diagnosed with type 1 diabetes; studies identified a
comparable group of participants without type 1 diabetes;
studies reported the prevalence of vaccination history in these
two groups or reported ORs or RRs for the association be-
tween vaccination history and type 1 diabetes.
Study characteristics were independently extracted from
the published reports by two investigators (G. R. Campbell
and S. R. Halliday). The details recorded were author, date of
publication, country, source of patients, age at diagnosis,
source of controls, and definition and source of information
about childhood vaccinations.
The quality of papers included in this review was assessed
independently by two investigators (S. R. Halliday and
E. Morgan) using the Newcastle–Ottawa scale (NOS) [9]. A
threshold score of seven or more was used to identify the
higher quality articles.
Statistical analysisAdjusted and unadjusted ORs or RRs and
their SEs were extracted from each study and entered into
Review Manager version 5.1 (Nordic Cochrane Centre,
Copenhagen, Denmark). When estimates were provided for
a combined vaccine, the same estimate was used for the analysis
of each individual vaccine. To account for the anticipated
heterogeneity between studies, a random effects model was
used to calculate an overall pooled estimate. A χ2 test was
obtained and the I2 statistic used to measure the extent of
heterogeneity [10]. For each vaccination, an initial analysis
was conducted using published unadjusted estimates, or age-
adjusted estimates when available. Further analyses were con-
ducted using estimates which were adjusted for additional
covariates if they had been provided. Sensitivity analyses were
conducted to investigate whether results differed on the basis of
study design (case–control or nested case–control/cohort) or
quality score (NOS score of seven or more or less than seven).
To check for publication bias, funnel plots were produced by
plotting the OR for each study against the SE of the natural
logarithm of the OR, and Egger tests were conducted to inves-
tigate funnel plot asymmetry [11].
Results
The results of the literature search are shown in ESMFig. 1. The
MEDLINE and EMBASE searches yielded 2,156 articles. After
screening titles and abstracts, 2,113 articles were excluded, leav-
ing 43 full text articles to be screened for eligibility. Following
this screen, 33 were excluded (listed in ESM Table 2),
leaving ten eligible articles [5, 6, 12–19]. Two additional
articles were identified by searching the reference lists of
these ten articles [20, 21]. Finally, five more articles were
identified as having cited one or more of the already
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identified articles [22–26]. One of the identified articles
had conducted two separate case–control studies, one
using controls from a community-based survey and the
other using friends and neighbourhood controls matched
by age and sex [13]. The multicentre EURODIAB publi-
cation [6] reported estimates from seven separate centres
with individual patient data available, but one of these was
omitted because the results had been previously presented
in a separate publication [15]. In total, 13,323 cases of
childhood diabetes from 23 studies were included in the
17 articles that contributed to this analysis.
Characteristics of the included studies are shown in
Table 1. They were predominantly case–control in design
including two nested case–control studies, with an additional
four cohort studies and one randomised controlled trial.
Eleven of the articles were from Europe, two from Australia
[20, 21] and the US [16, 18], and one each from Canada [13]
and Africa [22]. Type 1 diabetes cases were ascertained
through a diabetes register in seven articles.
All of the cohort studies accounted for age in their analyses
and all but two of the case–control studies matched controls to
cases by age [19, 22]. Most studies also matched controls by
sex. Further matching variables included location [12, 13, 24]
and length of enrolment [16]. Four articles provided estimates
after further adjustment for maternal educational level [20],
race/ethnicity and family history of type 1 diabetes [16], cal-
endar period [5], and healthcare consumption [26].
Methods of exposure ascertainment varied across studies
(Table 1). Ten of the 23 studies used a combination of
interview/questionnaires and medical records, seven studies
solely used medical records or register data, and the remaining
five studies obtained exposure data purely from recall [17,
19–21, 25]. Participants in one article were divided into three
birth cohorts to investigate the timing of vaccinations; cohort 1
consisted of control participants who had not been vaccinated
at all and cohorts 2 and 3 had been vaccinated at different ages
and calendar periods [14]. Published response rates varied
from 55% to 100%, although some studies did not report re-
sponse rates. However, this forms part of the NOS assessment.
Studies investigated a wide range of vaccinations
(ESM Table 3), of which measles, rubella, mumps and per-
tussis were the most commonly investigated, while H1N1
influenza, tick-borne encephalitis, hepatitis B, meningitis C
and smallpox were each reported in only one of the 17 articles.
Quality assessment The quality of each study report was
assessed by two independent reviewers (E. Morgan and
S. R. Halliday) using the NOS. Eleven of the 17 reports [5,
6, 12–17, 20, 24, 26] were rated as being of “good” quality,
with an NOS score of seven or more.
Overall findings Results from the meta-analyses are
summarised in Table 2. Both minimally adjusted and further
adjusted pooled estimates are presented. The upper line
of data shows the pooled results for all studies while the
lower line shows the pooled results after the elimination
of any results from the six studies which scored less than
seven on the NOS. Forest plots of the minimally adjusted
estimates for each type of vaccination are presented in
ESM Fig. 2.
Meta-analyses found no significant association between
any of the 11 vaccinations and the risk of type 1 diabetes.
For instance, a meta-analysis of the 15 studies that investigat-
ed measles found a non-significant decrease in the risk of
developing type 1 diabetes (OR 0.75 [95% CI 0.54, 1.05];
p=0.09), with strong evidence of heterogeneity (I2=84%,
p for heterogeneity <0.001). Results were minimally changed
after adjusted estimates were used. There was a high degree of
heterogeneity observed in most of the meta-analyses except
for studies investigating haemophilus influenza B (HiB) and
Bacillus Calmette–Guérin (BCG) vaccinations. None of the
Egger tests for the 11 vaccinations showed significant evi-
dence of funnel plot asymmetry, which would be indicative
of publication bias.
Results of the remaining vaccinations that were reported in
only one study each showed no significant associations with
H1N1 influenza, tick-borne encephalitis, hepatitis B, menin-
gitis C or smallpox.
Sensitivity analyses Further investigations of the associations
between vaccinations and risk of type 1 diabetes were con-
ducted in a number of sensitivity analyses.
Removal of the six studies that scored less than seven on
the NOS resulted in the levels of heterogeneity being consid-
erably reduced (Table 2, lower data lines). The pooled ORs
were little affected by this exclusion and all remained statisti-
cally non-significant.
Another sensitivity analysis was conducted to assess
whether there was a difference in the overall effect due to
study design; however, the estimates remained largely
unchanged (results not shown).
Discussion
This study found no evidence that any of the reported vacci-
nations were associated with the risk of childhood type 1
diabetes. These findings were little altered after adjustment
for potentially confounding factors. Results were also largely
unchanged after two sensitivity analyses investigating the
effect of study design and quality assessment score were
conducted.
The rationale that immunisations contribute to the risk of
type 1 diabetes is not supported by this systematic review. Our
findings in humans do not support animal studies which have
suggested that vaccination timing affects diabetes
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development in rodents [27]. Although studies have found
that countries without vaccination programmes have lower
rates of type 1 diabetes and that diabetes rates have in-
creased over time with the introduction of vaccination
programmes [28], our findings suggest that these differences
are not due to the vaccination programmes but rather to
other differences between countries or to other changes over
time. In support of our findings, the Diabetes Autoimmunity
Study found that there was no increase in the risk of devel-
oping beta-cell autoimmunity or type 1 diabetes with
vaccination (including hepatitis B, HiB, polio or diphtheria,
tetanus and pertussis [DTP]) or the timing of vaccinations
[29]. However, due to the small number of cases of beta cell
autoimmunity or type 1 diabetes (n=25), this study lacked
sufficient statistical power to detect an association, and
results should be interpreted with caution.
As far as we are aware, this is the first systematic review
and meta-analyses to investigate the association of routine
vaccinations and risk of childhood type 1 diabetes. This sys-
tematic review benefits from extensive searches and the
Table 2 Summary of meta-analyses results for vaccinations as risk factors for childhood type 1 diabetes
Vaccinationa Studies (n) Cases (n) Controls (n) Unadjusted/minimally adjusted analysis Fully adjusted analysis
OR (95% CI) p I2 (%) Hetero p OR (95% CI) p I2 (%) Hetero p
Morbilli/measles
All 15 2,822 9,314b 0.75 (0.54, 1.05) 0.09 84 <0.001 0.75 (0.54, 1.05) 0.09 84 <0.001
NOS ≥7 11 2,324 8,040b 1.03 (0.88, 1.21) 0.70 15 0.3 1.03 (0.88, 1.21) 0.71 15 0.3
Rubella/German measles
All 14 2,776 9,221b 0.85 (0.58, 1.26) 0.42 84 <0.001 0.85 (0.58, 1.26) 0.43 84 <0.001
NOS ≥7 11 2,319 8,046b 1.15 (0.96, 1.37) 0.14 21 0.25 1.15 (0.96, 1.37) 0.14 20 0.25
Parotitis/mumps
All 13 2,690 8,409b 0.81 (0.60, 1.12) 0.20 84 <0.001 0.81 (0.59, 1.11) 0.20 84 <0.001
NOS ≥7 11 2,427 7,987b 1.03 (0.90, 1.17) 0.67 5 0.4 1.03 (0.90, 1.17) 0.70 9 0.36
Pertussis/whooping cough
All 14 1,896 15,720 0.79 (0.53, 1.19) 0.26 74 <0.001 0.79 (0.53, 1.18) 0.25 74 <0.001
NOS ≥7 10 1,401 14,518 0.92 (0.71, 1.20) 0.55 27 0.2 0.92 (0.70, 1.21) 0.51 36 0.13
BCG
All 11 1,869 10,685 0.96 (0.76, 1.21) 0.75 25 0.2 0.96 (0.76, 1.21) 0.73 26 0.2
NOS ≥7 10 1,828 10,586 1.02 (0.85, 1.22) 0.87 0 0.53 1.01 (0.84, 1.22) 0.88 0 0.51
HiB
All 11 11,828 415,048b 1.04 (0.94, 1.14) 0.46 4 0.40 1.07 (0.97, 1.17) 0.17 0 0.61
NOS ≥7 10 3,223 379,675b 1.06 (0.96, 1.16) 0.24 0 0.47 1.08 (0.98, 1.19) 0.10 0 0.73
Tetanus
All 10 1,361 3,330 0.76 (0.43, 1.34) 0.34 63 0.004 0.76 (0.43, 1.34) 0.34 63 0.004
NOS ≥7 7 1,002 2,400 0.80 (0.47, 1.34) 0.39 40 0.13 0.80 (0.47, 1.34) 0.39 40 0.13
Diphtheria
All 9 1,015 2,686 0.99 (0.49, 2.00) 0.98 61 0.008 0.99 (0.49, 2.00) 0.98 61 0.008
NOS ≥7 6 656 1,756 1.02 (0.56, 1.85) 0.95 19 0.29 1.02 (0.56, 1.85) 0.95 19 0.29
Poliomyelitis
All 8 1,040 2,481 0.80 (0.39, 1.68) 0.56 54 0.03 0.80 (0.39, 1.68) 0.56 54 0.03
NOS ≥7 7 999 2,382 1.07 (0.61, 1.88) 0.82 5 0.39 1.07 (0.61, 1.88) 0.82 5 0.39
MMR
All 5 1,505 5,469b 0.58 (0.24, 1.40) 0.22 92 <0.001 0.53 (0.21, 1.38) 0.19 94 <0.001
NOS ≥7 3 1,242 5,347b 1.21 (0.99, 1.49) 0.07 0 0.56 1.21 (0.98, 1.49) 0.07 0 0.57
DTP
All 3 359 930 0.90 (0.15, 5.31) 0.91 84 0.002 0.90 (0.15, 5.31) 0.91 84 0.002
NOS ≥7 0 0 0 NA NA NA NA NA NA NA NA
Hetero p, p value for heterogeneity; NA, not applicable
a NOS ≥7 – analyses restricted to high quality studies which have an NOS score of seven or more
b Excludes one study with an unstated number of controls
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inclusion of data on 13,323 children with type 1 diabetes, thus
providing a sufficiently high statistical power to detect even
modest associations and having narrow 95% CIs for the OR
estimates. Most studies used clinical records or registers to
ascertain vaccination status and of those that were
questionnaire- or interview-based, most used medical records
to validate vaccination data and eliminate the risk of potential
recall bias.
Notwithstanding these strengths, there were a number of
limitations for this systematic review. Too few studies stratified
data according to the timing of vaccinations to adequately as-
sess whether the associations differed by timing of vaccination
as postulated by Classen and Classen [27, 28]. Only two arti-
cles gave further detail on the timing of vaccinations [14, 16].
In the Finnish study, Karvonen et al reported no difference in
the risk of type 1 diabetes in a cohort vaccinated against HiB at
age 3 months compared with a cohort vaccinated at 24 months
of age [14]. Similarly, a later US study did not find any asso-
ciation with diabetes risk when infants were vaccinated against
hepatitis B at birth compared with those who received their first
vaccination later in life [16].
Although the marked heterogeneity in the estimates for
most vaccinations is a further weakness of our study, this
was largely reduced when analyses were restricted to higher
quality studies.
This systematic review was limited in the variation of con-
founders adjusted for among studies, which could have result-
ed in residual confounding. The predominance of retrospec-
tive case–control studies in this review should be recognised
as a further limitation because the possibility remains that
participation was different for parents of case and control par-
ticipants and that participation rates may be higher in health
conscious parents who may be more likely to have their chil-
dren vaccinated. The reliance on parental recall of vaccina-
tions in five studies [17, 19–21, 25] can have limitations,
particularly for differences in recall between parents of case
and control children [30]. It could be that the parents of chil-
dren with type 1 diabetes are more mindful of their children’s
vaccination history. Alternatively, the strain and worry of hav-
ing a child with type 1 diabetes may overshadow the memory
of what vaccinations they had received at birth and conse-
quently lead to under-reporting. More recently established
prospective birth cohort studies should provide reliable vacci-
nation information [31]. However, even though cohort partic-
ipants are selected as being at a high risk, the small numbers of
cases of diabetes together with the uniformly high rates of
vaccination attained in many countries may mean that their
power to detect associations is limited.
In conclusion, this systematic review and meta-analysis
does not show evidence of an association between any of
the routine vaccinations investigated and childhood type 1
diabetes. Therefore, this study does not provide a rationale
for altering vaccination programmes based upon a subsequent
risk of type 1 diabetes. Future research in this area should
focus on the timing of vaccinations because mouse models
suggest this may be important, and only two studies included
in this review investigated vaccination timing [14, 16].
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